Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 197

Kakao and Daum close $9.4bn merger

Tencent and CyberAgent both recorded hefty exits as online messaging service Kakao joined forces with internet portal Daum in a reverse merger.

Oct 1, 2014

Zalando goes public in $664m IPO

The online fashion retailer, backed by Anders Holch Povlsen, Holtzbrinck and Tengelmann, floated near the top of its range and could raise up to $765m before the IPO closes.

Oct 1, 2014

Vitae aims to improve its life with $55m IPO

The pharmaceutical company, backed by Allergan and Boehringer Ingelheim, raised the cash after $109m of equity funding.

Sep 30, 2014

Molecular Partners thinks bigger for $134m IPO

The Johnson & Johnson-backed Switzerland-based protein developer is looking to go public after raising almost $60m in equity funding.

Sep 24, 2014

Rocket Internet sets range for $1.9bn flotation

The venture firm would raise the sum, which effectively doubles the expected size of the IPO, if it floats at the mid-point of its range.

Sep 24, 2014

Alibaba closes IPO at world record $25bn

Yahoo ended up securing $9.5bn in the offering, which broke the record previously held by Agricultural Bank of China.

Sep 22, 2014

Dermatological treatment company Dermira aims for $98m in IPO

Pharmaceutical company UCB will buy additional shares in the offering as Dermira, which is also backed by Maruho, seeks to raise funds for product development.

Sep 22, 2014

Zalando to fashion up to $813m from IPO

The online fashion brand, backed by Tengelmann, Holtzbrinck and Anders Holch Povlsen, will use the proceeds to support growth.

Sep 22, 2014

Big Deal: Alibaba goes public in record IPO

The China-based e-commerce company established its place at the internet's head table with an IPO set to close at $25bn, showing the value of strategic investment.

Sep 19, 2014

Proteon targets $69m to advance kidney disease treatment

The Pharmstandard-backed pharmaceutical company is seeking to raise the cash in an IPO four months after it closed part of a $45m series D round.

Sep 19, 2014
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here